IgA 신증 40여 년

키워드

참고문헌 (70)

1. Berger J, "Ses Depots intracapillaires d’IgA-IgG", J Urol, 73, pp.694~695 (1968)
2. 대한신장학회 등록위원회, "우리나라 신대체 요법의 현황", ~ (2007)
3. Galla JH, "IgA nephropathy", Kidney Int, 47, pp.377~387 (1995)
4. Simon P, "Epidemiologic data of primary glomerular diseases in western France", Kidney Int, 66, pp.905~908 (2004)
5. 김명재, "IgA nephropathy의 병리조직학적 검색", 대한신장학회잡지, 4, pp.197~210 (1985)
6. Choi IJ, "An analysis of 2361 cases of renal biopsy in Korea", Yonsei Med J, 32, pp.9~15 (1991)
7. 김기현, "신생검 증례에 의한 사구체 신질환의 분석", 대한내과학회지, 49, pp.674~682 (1995)
8. 오윤규, "성인 사구체 신염", 대한장학회지, 15, pp.289~299 (1996)
9. Chang JH, "Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience", Nephrol Dial Transplant, 24, pp.2406~2410 (2009)
10. 대한신장학회, "IgA 신병증 치료를 위한 다기관 공동 연구 보고서 (Protocol I): IgA 신병증의 예후요인 규명을 위한 후향적 다기관 공동 임상 연구" (1998), 의학문화사
11. Koyama A, "Natural history and risk factors for immunoglobulin A nephropathy in Japan", Am J Kidney Dis, 29, pp.526~532 (1997)
12. Fennessy M, "HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations", Kidney Int, 49, pp.477~480 (1996)
13. Yoshida H, "Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy", J Clin Invest, 96, pp.2162~2169 (1995)
14. 박미나, "IgA 신병증 환자에게 있어 ACE 유전자 다형성에 따른 Angiotensin receptor blocker의 치료 효과", The Korean Journal of Nephrology, 27(1), pp.13~19 (2008), 대한신장학회
15. Liu ZH, "Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schoenlein nephritis and IgA nephropathy?", Kidney Int, 51, pp.1938~1942 (1997)
16. Lim CS, "Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy", Clin Nephrol, 63, pp.61~67 (2005)
17. Qin W, "Peripheral B lymphocyte beta1,3 -galactosyltransferase and chaperone expression in immunoglobulin A nephropathy", J Intern Med, 258, pp.467~477 (2005)
18. Gharavi AG, "IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23", Nat Genet, 26, pp.354~357 (2000)
19. Hsu SI, "Racial and genetic factors in IgA nephropathy", Semin Nephrol, 28, pp.48~57 (2008)
20. van den Wall Bake AW, "Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy", Clin Exp Immunol, 74, pp.115~120 (1988)
21. Jones CL, "Polymeric IgA and immune complex concentrations in IgA-related renal disease", Kidney Int, 38, pp.323~331 (1990)
22. Long JA, "IgA deposits and acute glomerulonephritis in a patient with staphylococcal infection", Am J Kidney Dis, 48, pp.851~855 (2006)
23. Suzuki S, "Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy", Lancet, 343, pp.12~16 (1994)
24. Coppo R, "Roccatello D. Dietary antigens and primary immunoglobulin A nephropathy", J Am Soc Nephrol, 2(10), pp.S173~S180 (1992)
25. Emancipator SN, "Immunoregulatory factor in the pathogenesis of IgA nephropathy", Kidney Int, 38, pp.1216~1229 (1990)
26. Suzuki Y, "Potential immunopathogenic role of the mucosa- bone marrow axis in IgA nephropathy: insights from animal models", Semin Nephrol, 28, pp.66~77 (2008)
27. Mestecky J, "Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy", Contrib Nephrol, 104, pp.172~182 (1993)
28. Hiki Y, "O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy: fundamental study for precise structure and possible role", Contrib Nephrol, 111, pp.73~84 (1995)
29. Moldoveanu Z, "Patients with IgA nephropathy have increased serum galactose deficient IgA1 levels", Kidney Int, 71, pp.1148~1154 (2007)
30. Tomana M, "Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG", Kidney Int, 52, pp.509~516 (1997)
31. Hiki Y, "Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy", Nephron, 72, pp.429~435 (1996)
32. Suzuki H, "Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity", J Clin Invest, 119, pp.1668~1677 (2009)
33. Mathew TH, "Recurrence of disease following renal transplantation", Am J Kidney Dis, 12, pp.85~96 (1988)
34. Cuevas X, "Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation", Transplant Proc, 19, pp.2208~2209 (1987)
35. van den Wall Bake AW, "Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as a source of mesangial IgA", Am J Kidney Dis, 12, pp.410~414 (1988)
36. Lee TW, "Production of IL-2 and expression of IL-2 receptor in IgA nephropathy", Korean J Intern Med, 7, pp.31~39 (1992)
37. Schena FP, "Immunogenetic aspects of primary IgA nephropathy", Kidney Int, 48, pp.1998~2013 (1995)
38. Lai KN, "Increased mRNA encoding for transforming factor-beta in CD4+ cells from patients with IgA nephropathy", Kidney Int, 46, pp.862~868 (1994)
39. Imasawa T, "Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder", Kidney Int, 56, pp.1809~1817 (1999)
40. Suzuki H, "Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells", Kidney Int, 72, pp.319~327 (2007)
41. Moura IC, "Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy", J Am Soc Nephrol, 16, pp.2667~2676 (2005)
42. Cederholm B, "Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy", Proc Natl Acad Sci U S A, 85, pp.4865~4868 (1988)
43. Wyatt RJ, "Julian BA. Activation of complement in IgA nephropathy", Am J Kidney Dis, 12, pp.437~442 (1988)
44. Roos A, "Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease", J Am Soc Nephrol, 17, pp.1724~1734 (2006)
45. Nagata M, "Macrophages in childhood IgA nephropathy", Kidney Int, 48, pp.527~535 (1995)
46. de Caestecker MP, "Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy", Kidney Int, 44, pp.1298~1308 (1993)
47. Yoshioka K, "In situ expression of cytokines in IgA nephritis", Kidney Int, 44, pp.825~833 (1993)
48. Lim CS, "Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy", Nephrology, 8, pp.21~27 (2003)
49. Ihm C, "IgA aggregates stimulate monocyte chemotactic peptide-1 expression in human mesangial cells", Nephrology, 5, pp.99~103 (2000)
50. Gomez-Guerrero C, "Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy", Contrib Nephrol, 104, pp.127~137 (1993)
51. Novak J, "IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells", Contrib Nephrol, 157, pp.134~138 (2007)
52. Tam KY, "Macromolecular IgA1 taken from patients with familial IgA Nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro", Kidney Int, 75, pp.1330~1339 (2009)
53. Hricik DE, "Glomerulonephritis", N Engl J Med, 339, pp.888~899 (1998)
54. 진규복, "IgA 신증의 장기 예후", The Korean Journal of Nephrology, 25(3), pp.365~374 (2006), 대한신장학회
55. Berthoux FC, "Natural history of primary IgA nephropathy", Semin Nephrol, 28, pp.4~9 (2008)
56. Barratt J, "Treatment of IgA nephropathy", Kidney Int, 69, pp.1934~1938 (2006)
57. Reich HN, "Remission of proteinuria improves prognosis in IgA nephropathy", J Am Soc Nephrol, 18, pp.3177~3183 (2007)
58. Shen P, "Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients", Nephron Clin Pract, 106, pp.c157~c161 (2007)
59. Goto M, "A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study" (2009), Nephrol Dial Transplant
60. Jennette JC, "The immunohistology of IgA nephropathy", Am J Kidney Dis, 12, pp.348~352 (1988)
61. Lee SM, "IgA nephropathy: morphologic predictors of progressive renal disease", Hum Pathol, 13, pp.314~322 (1982)
62. Haas M, "Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases", Am J Kidney Dis, 29, pp.829~842 (1997)
63. Lee HS, "Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee’s glomerular grading system", Nephrol Dial Transplant, 20, pp.342~348 (2005)
64. Praga M, "Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial", J Am Soc Nephrol, 14, pp.1578~1583 (2003)
65. Li PK, "Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study", Am J Kidney Dis, 47, pp.751~760 (2006)
66. Pozzi C, "Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial", J Am Soc Nephrol, 15, pp.157~163 (2004)
67. Ballardie FW, "Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy", J Am Soc Nephrol, 13, pp.142~148 (2002)
68. "Southwest Pediatric Nephrology Study Group. Association of IgA nephropathy with steroid-responsive nephrotic syndrome", Am J Kidney Dis, 5, pp.157~164 (1985)
69. Tumlin JA, "Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy", Semin Nephrol, 24, pp.256~268 (2004)
70. Donadio JV Jr, "A controlled trial of fish oil in IgA nephropathy", N Engl J Med, 331, pp.1194~1199 (1994)

관련 논문AI추천